Core Insights - Waterdrop's subsidiary, Beijing Yifan Fengshun Pharmaceutical Technology Co., Ltd., has obtained a national invention patent for its "Intelligent Matching Technology for Clinical Drug Trial Patients," which addresses inefficiencies in patient recruitment for clinical trials [1][2] - The new technology integrates deep neural networks and natural language processing to enhance the efficiency and accuracy of patient matching, significantly accelerating the drug development process [1][3] Group 1: Technology and Innovation - The intelligent matching technology employs a dual-track approach of "numerical matching + semantic embedding matching," achieving end-to-end precise matching between patients and trial projects [2][3] - The system disaggregates patient information into numerical data (e.g., age, lab results) and clinical information (e.g., medical history), allowing for accurate numerical comparisons and semantic matching [2][3] - The technology has demonstrated a matching accuracy rate exceeding 92% and has improved recruitment efficiency by over 300%, reducing matching time from days to minutes [3] Group 2: Market Impact and Applications - The technology is expected to save pharmaceutical companies significant time and labor costs in patient recruitment while providing eligible patients with access to quality clinical trial resources [3][4] - The technology has been piloted in multiple top-tier hospitals and pharmaceutical companies, successfully matching nearly 1,000 patients and helping clinical trial projects meet recruitment goals 3-6 months ahead of schedule [3][4] - Yifan Pharmaceutical focuses on addressing the industry's challenges of slow recruitment and difficult matching, leveraging Waterdrop's extensive patient base and digital AI capabilities [4]

Core Viewpoint - Waterdrop Group's subsidiary, Beijing Yifan Fengshun Pharmaceutical Technology Co., Ltd., has developed a patented "Intelligent Patient Matching Technology" for clinical drug trials, addressing inefficiencies in patient recruitment [1][2]. Group 1: Technology Overview - The newly patented technology utilizes a dual-track approach of "numerical matching + semantic embedding matching" to achieve precise patient-trial project matching [2]. - The system disaggregates patient information into numerical data (e.g., age, lab results) and clinical history, while also breaking down trial inclusion/exclusion criteria into corresponding numerical and descriptive information [2]. - The technology boasts three core advantages: a 300% increase in recruitment efficiency, over 92% accuracy in matching, and strong adaptability to various data formats and trial criteria [2]. Group 2: Industry Impact - The application of this technology is expected to save pharmaceutical companies significant time and labor costs in patient recruitment, while also connecting eligible patients with high-quality clinical trial resources [3]. - The technology has been piloted in multiple top-tier hospitals and pharmaceutical companies, successfully matching nearly 1,000 patients and helping clinical trial projects meet recruitment goals 3-6 months ahead of schedule [3]. - Yifan Pharmaceutical focuses on addressing the industry pain points of slow recruitment and difficult matching, leveraging Waterdrop's extensive patient base and digital capabilities to enhance research efficiency for renowned pharmaceutical companies [3].